BIIB - Lilly's donanemeb remternetug set to dominate Alzheimer's treatment by 2030
2024-06-08 14:00:00 ET
More on Eli Lilly, Biogen
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
-
Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer’s drug
-
Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript)